Macedonia de Nord – Produse farmaceutice – Growth Hormone and Inhalation Therapy
Descriere
Growth Hormone and Inhalation Therapy
**I.1) Description**
The European Commission, represented by the Directorate-General for Health and Food Safety, is seeking to conclude a framework agreement for the supply of growth hormone and inhalation therapy products.
**II.1.1) Information about the contracting entity**
Official name: European Commission, Directorate-General for Health and Food Safety
Address: Rue de la Loi 200, 1049 Brussels, Belgium
Country: Belgium
Contact person: European Commission, Directorate-General for Health and Food Safety
**II.1.3) Communication**
The procurement documents are available for unrestricted and full direct access, free of charge, at: TED eDelivery
Tenders or requests to participate must be submitted electronically via the eDelivery portal
**II.2.1) Description of the procurement**
The European Commission, represented by the Directorate-General for Health and Food Safety, is seeking to conclude a framework agreement for the supply of growth hormone and inhalation therapy products.
The framework agreement will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.
The estimated value of the framework agreement is EUR 12 000 000.
**III.1.1) Conditions for participation**
In order to be eligible, economic operators must provide proof that they are established in the European Economic Area (EEA) or, if established in a third country, that they have a representative in the EEA.
Economic operators must also provide proof that they have not been declared in breach of their obligations relating to the payment of social security contributions or taxes in the European Union.
**III.1.3) Information and formalities necessary for evaluating if the requirements are met**
Economic operators must submit the following documents:
- A completed and signed declaration on honour
- A copy of the economic operator's registration document
- A copy of the economic operator's articles of association
- A copy of the economic operator's VAT certificate
- A copy of the economic operator's bank guarantee
- A copy of the economic operator's insurance certificate
**III.2.1) Conditions related to the contract**
The framework agreement will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.
The estimated value of the framework agreement is EUR 12 000 000.
The framework agreement will be concluded in accordance with the principles of transparency, equal treatment and non-discrimination.
**IV.2.1) Description of the procurement**
The European Commission, represented by the Directorate-General for Health and Food Safety, is seeking to conclude a framework agreement for the supply of growth hormone and inhalation therapy products.
The framework agreement will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.
The estimated value of the framework agreement is EUR 12 000 000.
**V.2.1) Information about the award criteria**
The award criteria will be based on the most economically advantageous tender, as defined in the procurement documents.
The award criteria will take into account the following factors:
- Price
- Quality
- Delivery time
- After-sales service
**VI.3) Additional information**
The procurement documents are available for unrestricted and full direct access, free of charge, at: TED eDelivery
Tenders or requests to participate must be submitted electronically via the eDelivery portal
The deadline for the submission of tenders or requests to participate is 15/09/2023 at 12:00 CET.
The deadline for the submission of questions is 01/09/2023 at 12:00 CET.
The European Commission, represented by the Directorate-General for Health and Food Safety, reserves the right to reject any tender or request to participate that does not comply with the procurement documents.
The European Commission, represented by the Directorate-General for Health and Food Safety, reserves the right to cancel the procurement procedure at any time.
**VII.2) Information about the award of the contract**
The award of the contract will be based on the most economically advantageous tender, as defined in the procurement documents.
The award of the contract will take place within 30 days of the deadline for the submission of tenders or requests to participate.
The award of the contract will be published on the TED eDelivery portal.
The contract will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.
The estimated value of the contract is EUR 12 000 000.
**VIII.2) Information about the award of the contract**
The award of the contract will be based on the most economically advantageous tender, as defined in the procurement documents.
The award of the contract will take place within 30 days of the deadline for the submission of tenders or requests to participate.
The award of the contract will be published on the TED eDelivery portal.
The contract will be concluded for a period of 48 months, with the possibility of renewal for a further 24 months.
The estimated value of the contract is EUR 12 000 000.
Coduri CPV
Documente și transmitere
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Achiziții similare
North Macedonia – Medical consumables – Laboratory consumables
PHO Centar For Public Health - SkopjeMacedonia de NordMedical consumablesProtective gearLaboratory glasswareTermen limită în 31 zilePublicat pe 12 nov. 2026
North Macedonia – Medical equipments, pharmaceuticals and personal care products – Repair and servising
University Institute of Radiology, SkopjeMacedonia de NordMedical equipments, pharmaceuticals and personal care productsMedical equipmentsTermen limită în 28 zilePublicat pe 11 nov. 2026
North Macedonia – Pharmaceutical products – Ostheosynthetic materials
PHI Specialized Hospital for Orthpedics and Traumatology "St.Erazmo" OhridMacedonia de NordPharmaceutical productsMedical equipments, pharmaceuticals and personal care productsTermen limită în 26 zilePublicat pe 10 nov. 2026
North Macedonia – Pharmaceutical articles – Medicinal Products for the Treatment of Rare Diseases in the Republic of North Macedonia for the Period May 2026 – December 2028
Ministry of Health of the Republic of North MacedoniaMacedonia de NordPharmaceutical articlesOphthalmologicalsCardiac therapy medicinal productsTermen limită în 26 zilePublicat pe 09 nov. 2026